M&A

J&J to acquire ADC drug developer Ambrx for $2B
BioPharma Dive
Mon, 01/8/24 - 11:35 am
JNJ
Ambrx
M&A
antibody-drug conjugate
JPMHC 2024
Novartis dances into JPM with $250M Calypso buyout, $185M RNAi alliance
Fierce Biotech
Mon, 01/8/24 - 11:33 am
Novartis
Calypso
M&A
RNAi
JPMHC 2024
All AbbVie's CEO wanted for Christmas was Cerevel—oh, and ImmunoGen, too
Fierce Biotech
Mon, 01/8/24 - 11:30 am
AbbVie
Richard Gonzalez
Cerevel Therapeutics
M&A
Stakes are high as biopharma gathers for JPM
Medical Marketing and Media
Sun, 01/7/24 - 04:18 pm
M&A
JPMHC 2024
Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference
Reuters
Fri, 01/5/24 - 11:25 am
M&A
JPMHC 2024
AbbVie
AstraZeneca
Bristol Myers Squibb
Carmot Therapeutics
Eli Lilly
Newly Launched Tome Biosciences Acquires Replace Therapeutics for $65M
BioSpace
Wed, 01/3/24 - 05:00 pm
Tome Biosciences
Replace Therapeutics
M&A
2 Biotechs That Could Get Bought Out in 2024
Yahoo/Motley Fool
Wed, 01/3/24 - 04:59 pm
M&A
BridgeBio Pharma
Cytokinetics
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on
Fierce Pharma
Tue, 01/2/24 - 10:11 pm
AbbVie
Immunogen
M&A
antibody-drug conjugate
Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche
BioSpace
Tue, 01/2/24 - 11:26 am
M&A
AstraZeneca
Gracell Biotechnologies
Bristol Myers Squibb
Rayze Bio
Roche
More 2024 predictions from leaders of medical marketing agencies
Medical Marketing and Media
Sun, 12/31/23 - 11:51 am
Amazon
innovation
artificial intelligence
M&A
pharma marketing
Inflation Reduction Act
Eli Lilly concludes POINT Biopharma acquisition for $1.4bn
Pharmaceutical Business Review
Sun, 12/31/23 - 11:40 am
Eli Lilly
Point Biopharma
M&A
radiopharmaceuticals
BMS enters radiopharma race with $4.1B acquisition of RayzeBio just 3 months after biotech went public
Fierce Biotech
Wed, 12/27/23 - 11:15 pm
Bristol Myers Squibb
RayzeBio
radiopharmaceuticals
M&A
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
BioSpace
Wed, 12/27/23 - 11:08 pm
AstraZeneca
Gracell
cell therapy
M&A
Bristol Myers to acquire brain drug developer Karuna for $14B
BioPharma Dive
Fri, 12/22/23 - 09:44 am
Bristol Myers Squibb
Karuna Therapeutics
schizophrenia
M&A
KarXT
Concentra scores another win as Theseus agrees to buyout offer
Fierce Biotech
Fri, 12/22/23 - 09:43 am
Concerta Biosciences
Theseus Pharmaceuticals
M&A
Failed Illumina and Sanofi Deals Shine Light on FTC Antitrust Crackdown
BioSpace
Wed, 12/20/23 - 06:41 pm
Illumina
Grail
Sanofi
Maze Therapeutics
FTC
M&A
antitrust
Activist Icahn prepares a second board challenge at Illumina -letter
Reuters
Tue, 12/19/23 - 10:11 am
Illumina
Grail
Carl Icahn
M&A
Leading clinical research network Centricity Research acquires North Carolina-based Lucas Research
CP Wire
Mon, 12/18/23 - 04:28 pm
Centricity Research
M&A
Lucas Research
CROs
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
Mon, 12/18/23 - 04:24 pm
Centricity Research
M&A
Lucas Research
CROs
Illumina to divest cancer test maker Grail after antitrust battles
Reuters
Sun, 12/17/23 - 09:58 pm
Illumina
M&A
Grail
antitrust

Pages